Clinical trials
Disability or Chronic Disease Leading to Disablement clinical trials
Below are recruiting disability or chronic disease leading to disablement clinical trials, each written for real people, not researchers. We’re tracking 688 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07185022Recruiting
Clot-busting drug through artery for medium-vessel stroke
This trial tests a clot-busting drug given directly into the arteries of the brain for people who have had a stroke due to a blockage in a medium-sized artery. It aims to see if this treatment can help improve recovery when started up to 72 hours after symptoms begin.
Fuyang, AnhuiAges 18 years+ - NCT07221344RecruitingPhase 1/Phase 2
Study of an experimental drug for early Alzheimer's disease
This study tests an investigational drug, ARO-MAPT-SC, which targets a protein involved in Alzheimer's disease. It is for people with early Alzheimer's to see if the drug is safe and can slow the disease.
East York, OntarioAges 18–80 - NCT07225049Recruiting
Integrated treatment for PTSD and chronic pain
This study tests a combined therapy for people who have both PTSD and chronic pain. It aims to see if treating both conditions together is more helpful than treating them separately.
New York, New YorkAges 18 years+ - NCT07234695RecruitingPhase 3
Levetiracetam to prevent seizures in adults with Down syndrome and Alzheimer's
This trial tests if levetiracetam, a seizure medication, can prevent seizures in adults with Down syndrome who also have Alzheimer's disease. It aims to help manage a common complication and improve quality of life.
Granada, AndalusiaAges 40 years+ - NCT07360977Recruiting
Broccoli supplement for Parkinson's and multiple sclerosis
This trial tests a natural compound (from broccoli sprouts) called glucoraphanin, which may help protect brain cells in people with Parkinson's disease or multiple sclerosis. It aims to see if taking this supplement can slow down or improve symptoms.
MessinaAges 1–75 - NCT00001539Recruiting
Understanding Symptoms After Lyme Disease Treatment
This research study examines why some people continue to have symptoms months after being treated for Lyme disease. Researchers will compare patients with ongoing symptoms to people who recovered well, to better understand what causes lasting problems and how to help.
Bethesda, MarylandAges 13–99 - NCT07422675RecruitingPhase 1
Study of a new treatment for Parkinson's with motor fluctuations
This study tests a new single-dose treatment for Parkinson's disease to see if it can help reduce 'off' time—when medication wears off and symptoms return. It is for people who experience motor fluctuations and are already on a stable medication routine.
Englewood, ColoradoAges 40–80 - NCT07508813Recruiting
Digital system to check and reduce disability risk in older adults
This study tests a digital tool that helps assess and reduce the risk of disability in older adults living in the community. It uses a smartphone app to monitor and guide personalized interventions.
Hangzhou, ZhejiangAges 65 years+ - NCT07554833Recruiting
Brain Stimulation for Parkinson's Motor and Memory Skills
This study tests whether repeated magnetic stimulation (rTMS) of the brain can help improve movement and thinking problems in people with Parkinson's disease. Researchers will measure how the treatment affects your motor control and cognitive function over the study period.
San Francisco, CaliforniaAges 50–90 - NCT07588503RecruitingPhase 1
FES Cycling With Blood Flow Restriction for Spinal Cord Injury
This study tests a new exercise method combining electrical stimulation (FES) and controlled blood flow restriction while you cycle. It's designed to improve heart health, blood sugar control, and fitness in people with spinal cord injuries.
Toronto, OntarioAges 18–75 - NCT07624448Recruiting
Group therapy for autism, intellectual disability, and emotional struggles
This study tests a group therapy program for children ages 8–12 who have autism and intellectual disability and struggle with managing their emotions. The therapy meets twice weekly and includes both the child and their caregiver, with the goal of helping them learn better ways to handle big feelings.
Kansas City, MissouriAges 8–12 - NCT06920004RecruitingPhase 3
Testing empasiprubart vs IVIg for chronic CIDP
This study tests an investigational drug called empasiprubart against standard IVIg in adults with CIDP. The goal is to see if it is safer and more effective for people who still have symptoms despite IVIg therapy.
Birmingham, AlabamaAges 18 years+ - NCT07017634RecruitingPhase 3
Novosis Putty for spine fusion in lumbar disc disease
This trial tests a new bone graft putty (Novosis Putty) used during a specific type of spine fusion surgery (TLIF) to treat a worn-out disc causing low back and leg pain. The goal is to see if it works as well as or better than current options.
Little Rock, ArkansasAges 21–80 - NCT06290141RecruitingPhase 3
Testing riliprubart vs. standard IVIg for CIDP
This trial tests whether a new medication called riliprubart works as well as the usual IVIg treatment for people with chronic inflammatory demyelinating polyneuropathy (CIDP). It may offer another option for managing your condition.
Homewood, AlabamaAges 18 years+ - NCT07782099Recruiting
Breathing muscle function in chronic neck pain
This study compares breathing muscle function between people with chronic neck pain and healthy individuals. It aims to see if neck pain affects breathing muscles, which might lead to new treatments.
Kocaeli, DerinceAges 18–65 - NCT07579832Recruiting
Monitoring care quality for older adults in long-term care
This study tracks how well long-term care services work for older adults with disabilities by collecting feedback from patients, their family caregivers, and care professionals through a smartphone app. It aims to understand and improve the quality of home-based care services in Taiwan.
Huwei, Yunlin CityAges 65 years+ - NCT06941233Recruiting
Peer support program for adults with new disabilities transitioning home
This study tests a remote peer navigator program to help adults with new physical disabilities from conditions like stroke or spinal cord injury adjust to living in the community. It uses a smartphone app to connect you with a trained peer for support and guidance.
Chicago, IllinoisAges 18 years+ - NCT07091630RecruitingPhase 3
A study of empasiprubart for chronic inflammatory demyelinating polyneuropathy (CIDP)
This study tests a new medicine called Empasiprubart for adults with ongoing CIDP. It aims to see if fewer symptoms return and if it can replace current treatments.
Birmingham, AlabamaAges 18 years+ - NCT07322887RecruitingPhase 2
Study of sul-238 for early untreated parkinson's disease
This study tests whether an experimental medicine called SUL-238 can improve energy levels in the brain cells of people with early, untreated Parkinson's. It uses a special type of MRI to see if the medicine affects brain energy.
GroningenAges 40 years+ - NCT05183152Recruiting
Non-invasive brain signal control for assistive devices
This study tests an assistive device that you control using signals from the brain and muscles without surgery. It may help people with movement problems communicate or operate devices using gentle, non-invasive sensing.
Austin, TexasAges 18–80 - NCT07543861RecruitingPhase 1
Standing Balance Training Study for Parkinson's Disease
This study tests a new way to help people with Parkinson's disease improve their balance and standing ability through guided exercises in a lab setting. Researchers want to see if this approach can safely help reduce balance problems and fall risk.
Ann Arbor, MichiganAges 50 years+ - NCT07523113Recruiting
Brain Fog Treatment for ME/CFS Using Cognitive Training
This study tests whether a computerized cognitive training program combined with a mild electrical nerve stimulation device (worn on the ear) can help improve thinking and memory problems in people with ME/CFS. The goal is to see if this approach helps with brain fog and daily functioning.
Birmingham, AlabamaAges 18 years+ - NCT06762431RecruitingPhase 1/Phase 2
CAR T-cell therapy plus lenalidomide for CLL
This trial tests a combination of two treatments—CAR T-cells (your own immune cells reprogrammed to attack cancer) and lenalidomide (a pill that boosts the immune system)—for people with chronic lymphocytic leukemia (CLL) that has not responded to or returned after at least one prior treatment. It aims to see if this combination is safe and works better than either alone.
Vitebsk, Select A StateAges 18 years+ - NCT06404632Recruiting
Healthy habits group program for adults with and without disabilities
This study tests a group program called LEV-G that helps adults build healthy everyday habits. It includes people with and without disabilities, and may support your health and well-being.
Stockholm, Stockholm, SwedenAges 15–80
Hear when a new Disability or Chronic Disease Leading to Disablement trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for disability or chronic disease leading to disablement?
- Yes. Clin2 currently lists 688 recruiting disability or chronic disease leading to disablement studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a disability or chronic disease leading to disablement trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a disability or chronic disease leading to disablement trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.